A Study to Evaluate the Efficacy and Safety of VX-150 in Treating Subjects With Pain Caused by Small Fiber Neuropathy
Clinical trial NCT03304522 · COMPLETED
Trial details
- NCT number
- NCT03304522
- Sponsor
- Vertex Pharmaceuticals Incorporated
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-20
- Primary completion
- 2018-10-12
- Enrollment
- 89
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.